The global clinical trials market size accounted for USD 120.98 billion in 2024 and is expected to exceed around USD 186.09 billion by 2034, growing at a CAGR of 4.4% from 2024 to 2034.
The clinical trials market refers to the production, distribution, and use of these clinical trials, which are a type of research that studies new tests and evaluates their effects on human health outcomes. Clinical trials are conducted for many reasons, including to determine whether a new drug or device is safe and effective to use for people, to study different ways to use standard treatments, and to determine which treatments will be more effective, easy to use, and decrease specific side effects. Clinical trials can test a medical, surgical, or behavioral intervention in people. The rising chronic diseases like cardiovascular disorders, diabetes, and cancers are significant drivers of the clinical trials market.
However, the restraining factors of the market include data management issues, budget constraints, and suitability in identifying and recruiting, which can restrict the growth of the market. The future scope of the market includes patient-centric approaches, collaborations & partnerships with research institutions and tech companies, integration of artificial intelligence (AI) and machine learning (ML), and digital health technologies, which will help the growth of the clinical trials market.
Published by Ajit Bansod
